Advertisement

Bulletin of Experimental Biology and Medicine

, Volume 143, Issue 2, pp 207–209 | Cite as

Oxidative stress in patients with chronic heart failure and type 2 diabetes mellitus

  • N. E. Arzamastseva
  • V. Z. Lankin
  • G. G. Konovalova
  • A. K. Tikhaze
  • F. T. Ageev
  • Yu. V. Lapina
  • O. Yu. Narusov
  • V. Yu. Mareev
  • Yu. N. Belenkov
Article

Abstract

Parameters of oxidative stress were studied in patients with chronic heart failure and/or type 2 diabetes mellitus. Chronic heart failure was accompanied by severe oxidative stress, while in patients with type 2 diabetes mellitus the signs of oxidative stress were less pronounced. The intensity of free radical oxidation in patients with chronic heart failure and type 2 diabetes mellitus was not higher compared to patients with chronic heart failure.

Key Words

chronic heart failure diabetes mellitus lipid hydroperoxides malonicdialdehyde antioxidant enzymes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    N. K. Zenkov, V. Z. Lankin, and E. B. Men’shchikova, Oxidative Stress. Biochemical and Pathophysiological Aspects [in Russian], Moscow (2001).Google Scholar
  2. 2.
    V. Z. Lankin and S. M. Gurevich, Dokl. Akad. Nauk SSSR, 226, No. 3, 705–708 (1976).PubMedGoogle Scholar
  3. 3.
    V. Z. Lankin, G. G. Konovalova, A. K. Tikhaze, et al., Byull. Eksp. Biol. Med., 136, No. 7, 49–52 (2003).Google Scholar
  4. 4.
    V. Z. Lankin, M. O. Lisina, N. E. Arzamastseva, et al., Ibid., 140, No. 1, 41–43 (2005).CrossRefGoogle Scholar
  5. 5.
    V. Z. Lankin, A. K. Tikhaze, and Yu. N. Belenkov, Kardiologiya, 40, No. 7, 48–61 (2000).Google Scholar
  6. 6.
    V. Z. Lankin, A. K. Tikhaze, and Yu. N. Belenkov, Ibid., 44, No. 2, 72–81 (2004).PubMedGoogle Scholar
  7. 7.
    L. V. Nedosugova, V. Z. Lankin, M. I. Balabolkin, et al., Byull. Eksp. Biol. Med., 136, No. 8, 152–155 (2003).Google Scholar
  8. 8.
    A. K. Tikhaze, V. Z. Lankin, E. A. Zharova, and S. V. Kolycheva, Ibid., 130, No. 10, 395–398 (2000).CrossRefGoogle Scholar
  9. 9.
    C. Beauchamp and I. Fridovich, Anal. Biochem., 44, No. 1, 276–287 (1971).PubMedCrossRefGoogle Scholar
  10. 10.
    V. Lankin and A. Tikhaze, Free Radicals, Nitric Oxide, and Inflammation: Molecular, Biochemical, and Clinical Aspects, Amsterdam (2003), Vol. 344, pp. 218–231.Google Scholar
  11. 11.
    J. Nourooz-Zadeh, J. Tajaddini-Sarmadi, and S. P. Wolff, Anal. Biochem., 220, No. 2, 403–409 (1994).PubMedCrossRefGoogle Scholar
  12. 12.
    D. E. Paglia and W. N. Valentine, J. Lab. Clin. Med., 70, No. 1, 158–169 (1967).PubMedGoogle Scholar
  13. 13.
    D. Steinberg, Circulation, 95, No. 4, 1062–1071 (1997).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2007

Authors and Affiliations

  • N. E. Arzamastseva
    • 1
  • V. Z. Lankin
    • 1
  • G. G. Konovalova
    • 1
  • A. K. Tikhaze
    • 1
  • F. T. Ageev
    • 1
  • Yu. V. Lapina
    • 1
  • O. Yu. Narusov
    • 1
  • V. Yu. Mareev
    • 1
  • Yu. N. Belenkov
    • 1
  1. 1.Institute of Clinical Cardiology, Russian Cardiology Research and Production CenterRussian Ministry of HealthMoscow

Personalised recommendations